Life Sciences Oxford BioDynamics’s Checkpoint Inhibitor Response Test (EpiSwitch CiRT) Now Available in the UK AIT News Desk Jun 21, 2022 Oxford BioDynamics Plc , a biotechnology company developing precision medicine tests for immune health based on the EpiSwitch 3D genomics platform,…
Life Sciences Oxford BioDynamics Announces US Launch Of Its Checkpoint Inhibitor Response Test (EpiSwitch CiRT)… AIT News Desk Feb 28, 2022 First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI) Provides…